the study of "the effect of the psychotropic (hypnotic) drugs, antipsychotic drugs, and/or antidepressant drugs on clinical symptoms, sleep quality, cognitive function, daily activity, health related quality of life, and survival in patients with chronic hypercapnic respiratory failure who have received long-term oxygen therapy and/or nocturnal noninvasive positive pressure ventilation for a long time."

the study of "the effect of the psychotropic (hypnotic) drugs, antipsychotic drugs, and/or antidepressant drugs on clinical symptoms, sleep quality, cognitive function, daily activity, health related quality of life, and survival in patients with chronic hypercapnic respiratory failure who have received long-term oxygen therapy and/or nocturnal noninvasive positive pressure ventilation for a long time." - the effect of the psychotropics on clinical course in patients with chronic hypercapnic respiratory failure

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000010608

Enrollment

600

Registered

2013-05-01

Start date

2013-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients with chronic hypercapnic respiratory failure receiving a long-term oxygen therapy and/or noninvasive positive pressure ventilation (NPPV)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients receiving long-term oxygen therapy and/or long-term NPPV

Exclusion criteria

Exclusion criteria: Patients who do not agree to participate in this study. Patients who can not understand our questionnaire.

Design outcomes

Primary

Measure	Time frame
Effect of habitual intake of hypnotics on ABGs, especially PaCO2	—

Secondary

Measure	Time frame
(1) Effect of habitual intake of hypnotics on hospitalization rate and hospitalization length due to respiratory deteriolation. (2) Effect of habitual intake of hypnotics on prognosis. (3) Relationships between habitual intake of hypnotics and other factors such as health related quality of life. (4) Investigation of the prevalence of prescription of hypnotics in patients receiving a long-term oxygen therapy and/or long-term NPPV. (5) Investigation of subjective preference of hypnotics.	—

Measure

Time frame

(1) Effect of habitual intake of hypnotics on hospitalization rate and hospitalization length due to respiratory deteriolation. (2) Effect of habitual intake of hypnotics on prognosis. (3) Relationships between habitual intake of hypnotics and other factors such as health related quality of life. (4) Investigation of the prevalence of prescription of hypnotics in patients receiving a long-term oxygen therapy and/or long-term NPPV. (5) Investigation of subjective preference of hypnotics.

—

Countries

Japan

Contacts

Public ContactTomomasa Tsuboi

National Hospital Organization Minami-Kyoto Hospital Department of Respiratory Medicine

tsuboit@skyoto.hosp.go.jp0774-52-0065

Outcome results